InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Thompson Elizabeth H.Z., Directeur de la Recherche et Développement. Officer active across 3 companies, notably Horizon Therapeutics Public Ltd Co. Aggregated, 20 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €1.9m. History available since 5 August 2021. The latest transaction was filed on 30 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Thompson Elizabeth H.Z.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
32,272 股Common StockSEC:0001861477-26-000005:0
16,508 股@ US$26.130.0095% mcap99.7% 占其流量Common StockSEC:0001861477-26-000005:1
50 股@ US$26.170.0000% mcap0.3% 占其流量Common StockSEC:0001861477-26-000005:2
6,715 股Common StockSEC:0001861477-26-000003:0
7,196 股Common StockSEC:0001415889-25-021961:0
694 股0Common StockSEC:0001415889-25-019153:0
694 股0Common StockSEC:0001415889-25-009778:0
1,452 股0Common StockSEC:0001415889-25-000609:0
1,452 股0Common StockSEC:0001415889-24-024534:0
1,452 股0Common StockSEC:0001415889-24-019057:0
1,452 股0Common StockSEC:0001415889-24-009851:0
14,575 股@ US$116.5041.9% 占其流量Ordinary SharesSEC:0001209191-23-052363:0
2,000 股0Common StockSEC:0001209191-23-018502:0
19,055 股Ordinary SharesSEC:0001209191-23-000896:0
8 股@ US$85.0150.0% 占其流量Ordinary SharesSEC:0001209191-22-042767:0
82 股@ US$85.010.2% 占其流量Ordinary SharesSEC:0001209191-22-041840:0
8,098 股@ US$115.6427.5% 占其流量Ordinary SharesSEC:0001209191-22-024924:0
13,999 股Ordinary SharesSEC:0001209191-22-002295:0
7,542 股@ US$106.341121.4% 占其流量Ordinary SharesSEC:0001209191-21-050212:0
12,077 股Ordinary SharesSEC:0001209191-21-045062:0
20 条申报中的 20 条
About Thompson Elizabeth H.Z.
Thompson Elizabeth H.Z. is Directeur de la Recherche et Développement. She is associated with Horizon Therapeutics Public Ltd Co, IGM Biosciences, Inc. and Acadia Pharmaceuticals INC. Across 17 filings in total, the 17 sampled filings cover the period from 2021-07-02 to 2026-03-26, with 0 in purchases and 3163681 in sales, and the most frequent transaction nature is Attribution.
